Evan Thackaberry - SVP, Head of Early Development at Vigil Neuroscience, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
SVP, Head of Early Development
Stock Symbol
VIGL on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Evan Thackaberry since 4/23/2024

Holdings reported by Evan Thackaberry for Vigil Neuroscience, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option Grant (Right to Buy) 65K $495K $7.62 Mar 1, 2023 Direct Common Stock
Common Stock 1.5K $5.63K $3.75 May 5, 2022 Direct

Transactions reported by Evan Thackaberry for Vigil Neuroscience, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.